Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance…
VIRUSES & VACCINES
A paper published by Paul Fidel, Jr., PhD, Professor and Director of the Center of…
Patients suffering from severe respiratory symptoms as a result of SARS-CoV-2 infection can rapidly generate…
The majority of children with COVID-19 in 26 countries fared well clinically compared to adults…
More than 300 scientists and clinicians from the federal government, industry and academia published a…
Herd immunity to Covid-19 could be achieved with less people being infected than previously estimated…
NIH investigators and colleagues have discovered that when the immune system first responds to infectious…
Regions with an early interest in face masks had milder COVID-19 epidemics, according to a…
As Americans continue to grapple with the novel coronavirus, one question is on a lot…
The virus SARS coronavirus 2 (SARS-CoV-2) is the known cause of coronavirus disease 2019 (COVID-19).…
